US Stock Market Move | Estimated fourth quarter revenue below guidance range, Eli Lilly (LLY.US) fell 6%.

On Tuesday, Eli Lilly (LLY.US) fell by 6% to $749.49. Eli Lilly is expecting fourth quarter revenue to be around $13.5 billion, approximately $400 million lower than the lower end of recent guidance. Revenue for 2024 is expected to reach approximately $45 billion, $4 billion higher than the mid-point of the company's initial 2024 expectations. The company plans to announce its fourth quarter earnings and 2025 guidance on February 6th.